CEL Swings to HK$2.06 Billion Interim Loss as Litigation Provision and Softer Investment Income Weigh on Results

Bulletin Express
09/11

China Everbright Limited (CEL) reported a HK$2.06 billion loss attributable to shareholders for the six months ended 30 June 2026, reversing a HK$399.30 million profit a year earlier. The downturn reflects a HK$2.17 billion litigation provision linked to an equity-transfer dispute and a weaker showing from the fund management segment.

Turnover climbed 60.2 % year on year to HK$4.49 billion, yet total income slipped 8.2 % to HK$1.90 billion as net investment income contracted 26.6 % to HK$1.24 billion. Earnings were further constrained by a HK$375.60 million impairment on advances to customers, up HK$109.81 million versus the prior-year period.

Segment analysis shows the Fund Management Business posting a HK$1.00 billion loss, versus a HK$462.00 million loss last year, hit by lower valuations and real-estate exposures. Earned management-fee income fell 15.7 % to HK$182.00 million. Conversely, the Principal Investments Business delivered HK$2.21 billion profit, a 22.3 % increase, aided by revaluations following listings of portfolio companies such as SJ Semiconductor and CXMT. Cornerstone holdings in China Everbright Bank and Everbright Securities added HK$824.33 million to segment income; CEL’s 20.73 % stake in Everbright Securities alone contributed HK$514.99 million in equity-accounted profit.

Basic and diluted loss per share stood at HK$(1.222), compared with earnings of HK$0.237 a year ago. The Board declared an interim dividend of HK$0.04 per share, 20 % below last year’s HK$0.05.

CEL’s balance sheet exhibited a HK$1.33 billion rise in total equity to HK$33.47 billion after issuing RMB3.00 billion (HK$3.37 billion) of perpetual medium-term notes. The gearing ratio eased to 79.0 % from 92.2 % at end-2025, while cash and equivalents totalled HK$7.65 billion. Assets under management reached HK$121.80 billion across 66 funds; CEL’s seed capital represented 29.3 % of this base.

Management highlighted persistent weakness in Chinese Mainland’s commercial real-estate market and ongoing legal proceedings as key risk factors. The company said it will appeal the adverse judgment that triggered the litigation provision and will continue to focus on technology-driven sectors, asset revitalisation and cost control in the second half of 2026.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10